Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
37.61
-0.75 (-1.96%)
Sep 3, 2026, 4:00 PM EDT - Market closed
Neurogene Market Cap
Neurogene has a market cap or net worth of $752.63 million as of September 3, 2026. Its market cap has increased by 168.51% in one year.
Market Cap
752.63M
Enterprise Value
535.58M
1-Year Change
168.51%
Ranking
Category
Stock Price
$37.61
ChartMarket Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $752.63M, an increase of 288.68%. That is a compound annual growth rate of 65.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 752.63M | 135.87% |
| Dec 31, 2025 | 319.09M | -6.03% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
| Dec 19, 2023 | 193.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 798.86M |
| DBV Technologies | 794.50M |
| 4D Molecular Therapeutics | 792.75M |
| Monopar Therapeutics | 789.15M |
| Aura Biosciences | 770.53M |
| Crescent Biopharma | 767.42M |
| Oculis Holding AG | 751.90M |
| Nuvectis Pharma | 751.33M |